BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 302827)

  • 1. Cell-mediated immunity to tumor antigen in Marek's disease: susceptibility of effector cells to antithymocyte serum and enhancement of cytotoxic activity by Vibrio cholerae neuraminidase.
    Sharma JM
    Infect Immun; 1977 Oct; 18(1):46-51. PubMed ID: 302827
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of cell-mediated immunity to Marek's disease tumor cells in chickens inoculated with Marek's disease vaccines.
    Sharma JM; Witter RL; Coulson BD
    J Natl Cancer Inst; 1978 Nov; 61(5):1273-80. PubMed ID: 213610
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cell-mediated cytotoxicity of lymphocytes from chickens inoculated with herpesvirus of turkey against a Marek's disease lymphoma cell line (MSB-1).
    Kitamoto N; Ikuta K; Kato S; Yamaguchi S
    Biken J; 1979 Mar; 22(1):11-20. PubMed ID: 317001
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cell-mediated cytotoxic response to cells bearing Marek's disease tumor-associated surface antigen in chickens infected with Marek's disease virus.
    Sharma JM; Coulson BD
    J Natl Cancer Inst; 1977 Jun; 58(6):1647-51. PubMed ID: 68120
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro cytotoxicity against Marek's disease lymphoblastoid cell lines after enzymatic removal of Marek's disease tumor-associated surface antigen.
    Schat KA; Murthy KK
    J Virol; 1980 Apr; 34(1):130-5. PubMed ID: 6966335
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Demonstration of Marek's disease tumor-associated surface antigen in chickens infected with nononcogenic Marek's disease virus and herpesvirus of turkeys.
    Schat KA; Calnek BW
    J Natl Cancer Inst; 1978 Sep; 61(3):855-7. PubMed ID: 211242
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Presence of adherent cytotoxic cells and non-adherent natural killer cells in progressive and regressive Marek's disease tumors.
    Sharma JM
    Vet Immunol Immunopathol; 1983 Dec; 5(2):125-40. PubMed ID: 6606892
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of T-cell surface determinants in three Marek's disease lymphoblastoid cell lines.
    Matsuda H; Ikuta K; Kato S
    Biken J; 1976 Mar; 19(1):29-32. PubMed ID: 180968
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction of specific cytotoxic T-cell activity against xenogeneic target cells in carp (Cyprinus carpio).
    Yamamoto K; Mukamoto M; Watarai S; Kodama H; Nakayasu C; Okamoto N
    Am J Vet Res; 2001 Apr; 62(4):599-603. PubMed ID: 11327471
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Natural killer cell activity in chickens: target cell analysis and effect of antithymocyte serum on effector cells.
    Sharma JM; Okazaki W
    Infect Immun; 1981 Mar; 31(3):1078-85. PubMed ID: 6971810
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Natural killer cell activity in chickens exposed to Marek's disease virus: inhibition of activity in susceptible chickens and enhancement of activity in resistant and vaccinated chickens.
    Sharma JM
    Avian Dis; 1981; 25(4):882-93. PubMed ID: 6279075
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Suppression of mitogen-induced proliferation of normal spleen cells by macrophages from chickens inoculated with Marek's disease virus.
    Lee LF; Sharma JM; Nazerian K; Witter RL
    J Immunol; 1978 May; 120(5):1554-9. PubMed ID: 659861
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cell-mediated immunity in Marek's disease: cytotoxic responses in resistant and susceptible chickens and relation to disease.
    Confer AW; Adldinger HK
    Am J Vet Res; 1980 Mar; 41(3):307-12. PubMed ID: 6445171
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Monoclonal antibody to chicken fetal antigen on Marek's disease lymphoblastoid cell line MDCC-MSB1.
    Ohashi K; Mikami T; Higashihara T; Kodama H; Izawa H
    Cancer Res; 1986 Nov; 46(11):5858-63. PubMed ID: 2428485
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-tumor immunity against Marek's disease-derived lymphoblastoid cell line (MSB-1).
    Sugimoto C; Kodama H; Mikami T
    Jpn J Vet Res; 1978 Oct; 26(3-4):57-67. PubMed ID: 739712
    [No Abstract]   [Full Text] [Related]  

  • 16. Nature of genetic resistance to Marek's disease in chickens.
    Lee LF; Powell PC; Rennie M; Ross LJ; Payne LN
    J Natl Cancer Inst; 1981 Apr; 66(4):789-96. PubMed ID: 6262555
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The mechanism of genetic resistance to Marek's disease in chickens.
    Powell PC; Lee LF; Mustill BM; Rennie M
    Int J Cancer; 1982 Feb; 29(2):169-74. PubMed ID: 6277808
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of Marek's disease tumor-associated surface antigen on MDCC-MSB1-clo.18 cells.
    Horie M; Ohashi K; Kodama H; Mikami T
    Int J Cancer; 1991 Jan; 47(2):238-43. PubMed ID: 1703127
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A nonproducer T lymphoblastoid cell line from Marek's disease transplantable tumor (JMV).
    Nazerian K; Stephens EA; Sharma JM; Lee LF; Gailitis M; Witter RL
    Avian Dis; 1977; 21(1):69-76. PubMed ID: 190995
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Syngeneic and allogeneic cell-mediated cytotoxicity against Marek's disease lymphoblastoid tumor cell lines.
    Schat KA; Shek WR; Calnek BW; Abplanalp H
    Int J Cancer; 1982 Feb; 29(2):187-94. PubMed ID: 6277809
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.